SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 14 filers reported holding SUMMIT THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $24,000 | -17.2% | 11,000 | -7.6% | 0.00% | – |
Q2 2018 | $29,000 | -81.2% | 11,900 | 0.0% | 0.00% | – |
Q1 2018 | $154,000 | +450.0% | 11,900 | +376.0% | 0.00% | – |
Q4 2017 | $28,000 | -9.7% | 2,500 | 0.0% | 0.00% | – |
Q3 2017 | $31,000 | +10.7% | 2,500 | 0.0% | 0.00% | – |
Q2 2017 | $28,000 | – | 2,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LANSDOWNE PARTNERS (UK) LLP | 2,667,350 | $7,922,000 | 0.33% |
Polar Capital LLP | 4,500,000 | $13,365,000 | 0.12% |
Inscription Capital, LLC | 17,000 | $50,000 | 0.03% |
BBR PARTNERS, LLC | 50,000 | $149,000 | 0.02% |
Checchi Capital Advisers, LLC | 20,000 | $59,000 | 0.01% |
Cornerstone Investment Partners, LLC | 34,825 | $103,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 49,257 | $146,000 | 0.00% |
Renaissance Technologies | 361,112 | $1,073,000 | 0.00% |
HSBC HOLDINGS PLC | 150,975 | $448,000 | 0.00% |
CAPTRUST FINANCIAL ADVISORS | 11,000 | $35,000 | 0.00% |